LINC01859

Across TCGA pan-cancer cohorts, LINC01859 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC01859 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC01859 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01859 expression acts as an unfavorable survival marker, although some lineages such as UCS and ESCA show a favorable association.

BLCA, UCS, and LGG are the cancer types where LINC01859 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.450	0.643	.005	66	view →
UCS	DFS	Tertile	III,IV	0.694	0.190	.010	48	view →
LGG	DFS	Tertile	All	0.572	0.779	<.001	42	view →
ESCA	DFS	Tertile	IV	0.826	0.284	.034	36	view →
LUAD	OS	Tertile	III,IV	0.109	0.660	<.001	36	view →
UCEC	DFS	Tertile	All	0.748	0.854	.007	36	view →
UVM	OS	Tertile	All	0.276	0.616	.024	18	view →
READ	OS	Tertile	III,IV	0.287	0.772	.030	18	view →
LIHC	DFS	Tertile	II,III,IV	0.097	0.485	<.001	18	view →
SKCM	DFS	Tertile	II,III,IV	0.100	0.237	.014	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
SARC	OS	Tertile	All	0.585	0.807	.002	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

LINC01859–BLCA (DFS)

Open the BLCA breakdown →